PRA at a glance
PROASSURANCE CORP (PRA, SEC CIK 1127703) filed its latest 10-K annual report on February 23, 2026, a 10-Q quarterly report on May 5, 2026, an 8-K current report on June 26, 2026 and Form 4 insider filings as recently as June 26, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), PROASSURANCE CORP (PRA) reported revenue of $1.1 billion (down 4.6% from FY2024) and net income of $50.9 million. Diluted EPS was $0.99.
- As of March 31, 2026, 30 institutional investment managers tracked by SignalX reported holding PROASSURANCE CORP (PRA) shares worth $549.5 million in 13F-HR filings.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $1.1B
- −4.6% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 30 funds
- $549.5M · +2 vs prior quarter
- Latest 8-K
- Jun 26, 2026
- Item 5.01 · Item 2.01 · Item 3.03
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business: Specialty property and casualty (P&C) insurance, with focus on medical professional liability (MPL) and workers' compensation segments
- New 100% quota share reinsurance agreement in Q2 2025 for legal professional liability policies, impacting ceded premiums ratio
- Strategic emphasis on improving profitability via proactive premium volume management, ceasing Syndicate 1729 participation for 2024
- Notable quantitative: Net favorable reserve development $79.8 million in 2025, up 116% from $36.9 million in 2024
- Unusual: Incorporation of podiatric and chiropractic policies into MPL treaty effective October 1, 2024, expanding risk coverage
Risk Factors
- Regulatory risk: expiration of Terrorism Risk Insurance Act (TRIA) at end of 2027 could increase terrorism loss exposure and raise premium costs
- Geopolitical risk: ongoing exposure to aviation losses linked to Russia’s invasion of Ukraine in open Lloyd’s Syndicate 6131 2021 underwriting year
- Operational risk: reliance on independent agents and brokers whose loss or consolidation could adversely impact new business acquisition and retention
- Competitive risk: intensified competition in medical professional liability market from mutual insurers with lower ROE and aggressive multistate entities
- Financial risk: $335 million reinsurance receivable on unpaid losses subject to reinsurer credit and payment timing uncertainties potentially affecting liquidity
Management Discussion & Analysis
- Revenue details not explicitly disclosed in MD&A provided; gross premiums by product: Specialty P&C 71%, Workers' Compensation 23% of consolidated gross premiums written in 2025
- No explicit profit/margin % figures given; focus on combined ratio, underwriting profitability and ROE targeting 700 bps above 10-year US Treasury of 11.2% (approx. 18.2% target ROE)
- Best performing segment: Specialty P&C (largest, 71% of premiums, 86% of reserve gross losses); Worst pressure in Workers’ Compensation with rate pressure and loss cost declines
- Forward outlook: Merger with The Doctors Company expected by June 30, 2026 with regulatory approvals pending; risks include healthcare market consolidation, social inflation, tort reform erosion, and regulatory timing uncertainties
AI summary of the PRA 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Mar 31, 2026
Management Discussion & Analysis
- Revenue $262.6M, down $9.4M YoY; net premiums earned $223.5M, down $12.8M
- Net income $8.5M vs $5.8M loss YoY; combined ratio 110.4% vs 115.6%
- Best segment Specialty P&C premiums $172.1M; worst Segregated Portfolio Cell Reinsurance, down 6.4% to $10.8M
- Operating cash flow $(21.3)M vs $(11.6)M YoY; cash and liquid investments $143M
- Headwinds: competitive pricing, higher paid-loss trends; no 2026 dividends expected before proposed merger closing
Risk Factors
- No Risk Factors section provided in the submitted filing excerpt
- No new or changed risk factors identifiable from the available text
- Share-repurchase authorization: $55.902 million remaining under the $600 million plan
- No director or officer trading-plan changes during three months ended March 31, 2026
AI summary of the PRA 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 5.01: Changes in Control of Registrant
- Change of control completed at the Effective Time through merger with Merger Sub
- ProAssurance remains the surviving corporation but is now wholly owned by The Doctors Company
Item 2.01: Completion of Acquisition or Disposition of Assets
- Merger closing triggered complete restatement of ProAssurance’s certificate of incorporation and bylaws
- Governance documents filed as Exhibits 3.1 and 3.2, making amended shareholder rights and corporate governance terms effective for investors
Item 3.03: Material Modification to Rights of Security Holders
- Rights modification details incorporated from Items 2.01, 3.01, 5.01 and 5.03
- Investor impact depends on the referenced transaction, listing status, control change and governing-document amendments
Item 8.01: Other Events
- All required insurance-regulatory approvals received as of June 23, 2026, removing the primary remaining regulatory hurdle
- Merger closing expected June 26, 2026, subject to customary conditions being satisfied or waived
Item 8.01: Other Events
- Merger with The Doctors Company remains on track, with ProAssurance becoming its wholly owned subsidiary
- Stockholders approved the transaction June 24, 2025; FTC antitrust waiting period terminated July 2, 2025
AI summaries of PRA 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for PRA
Don't miss the next PRA filing
- Alerts as it files. A push when PRA files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut PRA, by share count.
- Ask anything. An AI agent that reads every PRA filing and answers with sources.
PRA alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| SYPHAX SCOTT C | D | Jun 26, 2026 | 25,184 | $25.00 |
| BIELEN RICHARD J | D | Jun 26, 2026 | 10,621 | $25.00 |
| FRANCIS ROBERT DAVID | D | Jun 26, 2026 | 8,764 | - |
| FRANCIS ROBERT DAVID | D | Jun 26, 2026 | 11,778 | - |
| COBARRUBIAS FABILOA | D | Jun 26, 2026 | 25,184 | $25.00 |
| Pierce Staci | D | Jun 26, 2026 | 10,621 | $25.00 |
| Angiolillo Bruce D | D | Jun 26, 2026 | 35,652 | $25.00 |
| FRANCIS ROBERT DAVID | D | Jun 26, 2026 | 31,196 | $25.00 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $1.1B | $1.2B | $1.1B | |
| Net Income | -$38.6M | $52.7M | $50.9M | |
| Net Margin | -3.4% | 4.6% | 4.6% | |
| Balance Sheet | ||||
| Total Assets | $5.6B | $5.6B | $5.4B | |
| Equity | $1.1B | $1.2B | $1.3B | |
| ROE | -3.5% | 4.4% | 3.8% | |
| Per Share | ||||
| EPS | $-0.73 | $1.03 | $0.99 | |
| Cash Flow | ||||
| Operating CF | -$49.9M | -$10.7M | -$25.6M | |
Source: XBRL data in PROASSURANCE CORP (PRA)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate PRA share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q1 2026 | 30 | $549.5M |
| Q4 2025 | 28 | $531.3M |
| Q3 2025 | 29 | $525.1M |
| Q2 2025 | 29 | $501.9M |
| Q1 2025 | 26 | $379.4M |
| Q4 2024 | 20 | $231.1M |
| Q3 2024 | 18 | $134.9M |
- Renaissance Technologies LLC+834.7K (+641%)
- Millennium Management+317.0K (+41%)
- Goldman Sachs Group+251.9K (+49%)
- Morgan Stanley+56.3K (+4%)
- Bank of America Corp+50.9K (+68%)
- Dimensional Fund Advisors−1.29M (-47%)
- Wells Fargo & Co−37.9K (-66%)
- JPMorgan Chase & Co−17.8K (-13%)
- BNY Mellon−12.9K (-4%)
- BlackRock−9.4K (-0%)
- Vanguard Group Inc−5.30M
Source: 13F-HR filings on SEC EDGAR (aggregated from 180 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
PRA filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 8-K | Jun 26, 2026 | - | Analysis | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 8-K | Jun 23, 2026 | - | Analysis | - |
| 8-K | Jun 2, 2026 | - | Analysis | |
| 10-Q | May 5, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | May 5, 2026 | - | Analysis | - |
| SC 13G | Apr 30, 2026 | - | - | |
| SC 13G | Apr 29, 2026 | - | - | |
| 4 | Feb 26, 2026 | - | - | - |
| 4 | Feb 26, 2026 | - | - | - |
| 4 | Feb 26, 2026 | - | - | - |
| 4 | Feb 26, 2026 | - | - | - |
Related Financials companies
- ALL · AllstateFire, Marine & Casualty Insurance
- ACIC · AMERICAN COASTAL INSURANCE CorpFire, Marine & Casualty Insurance
- AII · American Integrity Insurance Group, Inc.Fire, Marine & Casualty Insurance
- AIG · American International GroupFire, Marine & Casualty Insurance
- AMSF · AMERISAFE INCFire, Marine & Casualty Insurance
- ACGL · Arch Capital GroupFire, Marine & Casualty Insurance
- ASIC · Ategrity Specialty Insurance Co HoldingsFire, Marine & Casualty Insurance
- BRK-A · Berkshire Hathaway IncFire, Marine & Casualty Insurance
PRA SEC filings: frequently asked questions
Which institutions hold PRA stock?
As of March 31, 2026, the largest PROASSURANCE CORP (PRA) holders among the 13F filers tracked by SignalX were BlackRock ($179.9 million), Vanguard Portfolio Management LLC ($68.7 million), Vanguard Capital Management LLC ($55.4 million), State Street Corp ($47.0 million), Dimensional Fund Advisors ($35.7 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was PRA's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), PROASSURANCE CORP (PRA) reported revenue of $1.1 billion (down 4.6% from FY2024) and net income of $50.9 million. Diluted EPS was $0.99. The figures come from the XBRL data in the 10-K.
What are the main risks in PRA's latest 10-K?
In the 10-K filed February 23, 2026, PROASSURANCE CORP (PRA) flagged: Regulatory risk: expiration of Terrorism Risk Insurance Act (TRIA) at end of 2027 could increase terrorism loss exposure and raise premium costs. Geopolitical risk: ongoing exposure to aviation losses linked to Russia’s invasion of Ukraine in open Lloyd’s Syndicate 6131 2021 underwriting year. (AI summary of the Risk Factors section.)
What did PRA report in its latest 8-K?
PROASSURANCE CORP (PRA) filed an 8-K on June 26, 2026 reporting Item 5.01 (Changes in Control of Registrant), Item 2.01 (Completion of Acquisition or Disposition of Assets) and Item 3.03 (Material Modification to Rights of Security Holders). Change of control completed at the Effective Time through merger with Merger Sub.
What are the latest PRA SEC filings?
PROASSURANCE CORP (PRA) filed its latest 10-K annual report on February 23, 2026, a 10-Q quarterly report on May 5, 2026, an 8-K current report on June 26, 2026 and a Form 4 insider filing on June 26, 2026.
What is PRA's SEC CIK number?
PROASSURANCE CORP (PRA)'s SEC Central Index Key (CIK) is 1127703. EDGAR lists every PRA filing under that number.
Ask anything about PRA
The research agent reads PRA's filings, financials, insider trades and 13F holders, then answers with sources.